Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis
ABSTRACT Background The coronavirus disease (COVID-19) pandemic affected the prompt diagnosis and treatment of Acute myocardial infarction (AMI). Aim: To characterize the clinical profile of patients with AMI during the COVID-19 pandemic, comparing them with a historical cohort. Material and Meth...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Médica de Santiago
2021
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500672 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872021000500672 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720210005006722021-11-03Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosisCataldo,PablaVerdugo,Fernando J.Bonta,CamilaDauvergne,ChristianGarcía,AlfonsoMéndez,ManuelUriarte,PolentziPineda,FernandoDuarte,ManuelSued,RaúlFuica,PabloTorres,GonzaloSandoval,Jorge Cardiac Catheterization COVID-19 Myocardial Infarction Percutaneous Coronary Intervention ABSTRACT Background The coronavirus disease (COVID-19) pandemic affected the prompt diagnosis and treatment of Acute myocardial infarction (AMI). Aim: To characterize the clinical profile of patients with AMI during the COVID-19 pandemic, comparing them with a historical cohort. Material and Methods: A case-control study of 96 patients with AMI transferred to a high-volume percutaneous coronary intervention (PCI) hospital between March and July 2020, and a historical cohort of 269 patients transferred during the same period in 2019. Results: When comparing patients transferred during the pandemic with those of the historical cohort, the former were younger (63 ± 12 vs 68 ± 12 years, p < 0.01), had a higher frequency of hypertension (66 vs 45%, p < 0.01) and of smoking (40% vs 25%, p < 0.01). Also, during COVID-19 outbreak a higher proportion of patients had ST-elevation AMI consulting > 12 hours from the onset of symptoms (44 vs 0%, p < 0.01), a higher median door-to-device time (4 vs 3 hours, p < 0.01), a higher use of primary percutaneous coronary intervention (97 vs 71%, p < 0.01), and higher frequencies of cardiogenic shock (20 vs 4%, p < 0.01) and mechanical complications (10% vs 2%, p < 0.01). Patients during COVID pandemic had a higher thirty-day overall (20 vs 1.4%, p < 0.01) and cardiovascular mortality (13 vs 1%, p < 0.01). During the outbreak, 40% of patients had positive COVID-19 status, which was a predictor for thirty-day overall mortality (Risk ratio 2.90; 95% confidence intervals 1.14-7.36). Conclusions: During the pandemic patients with AMI exhibited delays in consultations and treatment, higher morbidity, and increased mortality. COVID-19 positivity was associated to worse thirty-day overall survival.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.5 20212021-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500672en10.4067/s0034-98872021000500672 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
Cardiac Catheterization COVID-19 Myocardial Infarction Percutaneous Coronary Intervention |
spellingShingle |
Cardiac Catheterization COVID-19 Myocardial Infarction Percutaneous Coronary Intervention Cataldo,Pabla Verdugo,Fernando J. Bonta,Camila Dauvergne,Christian García,Alfonso Méndez,Manuel Uriarte,Polentzi Pineda,Fernando Duarte,Manuel Sued,Raúl Fuica,Pablo Torres,Gonzalo Sandoval,Jorge Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
description |
ABSTRACT Background The coronavirus disease (COVID-19) pandemic affected the prompt diagnosis and treatment of Acute myocardial infarction (AMI). Aim: To characterize the clinical profile of patients with AMI during the COVID-19 pandemic, comparing them with a historical cohort. Material and Methods: A case-control study of 96 patients with AMI transferred to a high-volume percutaneous coronary intervention (PCI) hospital between March and July 2020, and a historical cohort of 269 patients transferred during the same period in 2019. Results: When comparing patients transferred during the pandemic with those of the historical cohort, the former were younger (63 ± 12 vs 68 ± 12 years, p < 0.01), had a higher frequency of hypertension (66 vs 45%, p < 0.01) and of smoking (40% vs 25%, p < 0.01). Also, during COVID-19 outbreak a higher proportion of patients had ST-elevation AMI consulting > 12 hours from the onset of symptoms (44 vs 0%, p < 0.01), a higher median door-to-device time (4 vs 3 hours, p < 0.01), a higher use of primary percutaneous coronary intervention (97 vs 71%, p < 0.01), and higher frequencies of cardiogenic shock (20 vs 4%, p < 0.01) and mechanical complications (10% vs 2%, p < 0.01). Patients during COVID pandemic had a higher thirty-day overall (20 vs 1.4%, p < 0.01) and cardiovascular mortality (13 vs 1%, p < 0.01). During the outbreak, 40% of patients had positive COVID-19 status, which was a predictor for thirty-day overall mortality (Risk ratio 2.90; 95% confidence intervals 1.14-7.36). Conclusions: During the pandemic patients with AMI exhibited delays in consultations and treatment, higher morbidity, and increased mortality. COVID-19 positivity was associated to worse thirty-day overall survival. |
author |
Cataldo,Pabla Verdugo,Fernando J. Bonta,Camila Dauvergne,Christian García,Alfonso Méndez,Manuel Uriarte,Polentzi Pineda,Fernando Duarte,Manuel Sued,Raúl Fuica,Pablo Torres,Gonzalo Sandoval,Jorge |
author_facet |
Cataldo,Pabla Verdugo,Fernando J. Bonta,Camila Dauvergne,Christian García,Alfonso Méndez,Manuel Uriarte,Polentzi Pineda,Fernando Duarte,Manuel Sued,Raúl Fuica,Pablo Torres,Gonzalo Sandoval,Jorge |
author_sort |
Cataldo,Pabla |
title |
Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
title_short |
Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
title_full |
Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
title_fullStr |
Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
title_full_unstemmed |
Consequences of COVID-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
title_sort |
consequences of covid-19 pandemic on myocardial infarction reperfusion therapy and prognosis |
publisher |
Sociedad Médica de Santiago |
publishDate |
2021 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500672 |
work_keys_str_mv |
AT cataldopabla consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT verdugofernandoj consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT bontacamila consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT dauvergnechristian consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT garciaalfonso consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT mendezmanuel consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT uriartepolentzi consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT pinedafernando consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT duartemanuel consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT suedraul consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT fuicapablo consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT torresgonzalo consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis AT sandovaljorge consequencesofcovid19pandemiconmyocardialinfarctionreperfusiontherapyandprognosis |
_version_ |
1718437202415845376 |